Literature DB >> 18418228

Th2-dependent cytokine release in patients treated with coronary angioplasty.

Natale Daniele Brunetti1, Martino Pepe, Irene Munno, Fabio Tiecco, Donato Quagliara, Luisa De Gennaro, Antonio Gaglione, Matteo Di Biase, Stefano Favale.   

Abstract

AIM: The aim of this study is to investigate the T helper (Th)2-dependent release of interleukin(IL)-4 and IL-13 in patients with unstable angina treated with coronary angioplasty (PCI).
METHODS: This study involved 48 consecutive patients with unstable angina who underwent PCI. Blood samples were taken before and 48 h after PCI to evaluate serum IL-4 and IL-13 levels. Coronary atherosclerosis was assessed in terms of the severity of the treated lesions and the presence of multivessel disease, and compared with IL release.
RESULTS: Before and after PCI, serum IL-4 levels were, respectively, 53.1+/-110.7 and 35.1+/-16.9 pg/ml (P not significant), and serum IL-13 levels 6.7+/-3.7 and 6.0+/-2.9 pg/ml (P<0.05). A correlation was present between the severity of the treated coronary lesions and serum IL-13 levels (r 0.36; P<0.05). The patients with multivessel coronary artery disease had a higher periprocedure ratio of IL-4 than those with single-vessel coronary artery disease (1.46+/-0.76 vs. 0.89+/-0.34, P<0.001).
CONCLUSION: A significant decrease was observed in Th2-dependent IL concentrations after PCI; increased Th2-dependent IL levels before PCI seem to correlate with the severity of coronary atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418228     DOI: 10.1097/MCA.0b013e3282f3fbcb

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  5 in total

1.  A₁ adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice.

Authors:  Bunyen Teng; Jonathan D Smith; Michael E Rosenfeld; Peggy Robinet; Mary E Davis; R Ray Morrison; S Jamal Mustafa
Journal:  Cardiovasc Res       Date:  2014-02-12       Impact factor: 10.787

2.  IL-19 reduces ligation-mediated neointimal hyperplasia by reducing vascular smooth muscle cell activation.

Authors:  Stephen Ellison; Khatuna Gabunia; James M Richards; Sheri E Kelemen; Ross N England; Dan Rudic; Yasu-Taka Azuma; M Alexandra Munroy; Satoru Eguchi; Michael V Autieri
Journal:  Am J Pathol       Date:  2014-05-09       Impact factor: 4.307

3.  Lymphocyte subset characterization in patients with early clinical presentation of coronary heart disease.

Authors:  Natale Daniele Brunetti; Carmine D'Antuono; Michele Rana; Girolamo D'Arienzo; Luisa De Gennaro; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

4.  Knockout of CD8 delays reendothelialization and accelerates neointima formation in injured arteries of mouse via TNF-α inhibiting the endothelial cells migration.

Authors:  Jun-Meng Zhang; Ying Wang; Yan-Ju Miao; Yi Zhang; Yi-Na Wu; Li-Xin Jia; Yong-Fen Qi; Jie Du
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

5.  Enhanced neointima formation following arterial injury in immune deficient Rag-1-/- mice is attenuated by adoptive transfer of CD8 T cells.

Authors:  Paul C Dimayuga; Kuang-Yuh Chyu; Jonathan Kirzner; Juliana Yano; Xiaoning Zhao; Jianchang Zhou; Prediman K Shah; Bojan Cercek
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.